Journal
CELL REPORTS
Volume 25, Issue 7, Pages 1898-+Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2018.10.061
Keywords
-
Categories
Funding
- National Cancer Institute [CA181340-01, CA225191-01, CA215452-01, CA215226-01]
- Alex's Lemonade Stand Foundation
- Anna Fuller Fund
- Cancer Prevention Research Institute of Texas [RR150093]
- Center for Cancer Research of the Intramural Program of the National Cancer Institute
- McNair Medical Institute
- Curing Kids Cancer
Ask authors/readers for more resources
Down syndrome (DS, trisomy 21) is associated with developmental abnormalities and increased leukemia risk. To reconcile chromatin alterations with transcriptome changes, we performed paired exogenous spike-in normalized RNA and chromatin immunoprecipitation sequencing in DS models. Absolute normalization unmasks global amplification of gene expression associated with trisomy 21. Overexpression of the nucleosome binding protein HMGN1 (encoded on chr21q22) recapitulates transcriptional changes seen with triplication of a Down syndrome critical region on distal chromosome 21, and HMGN1 is necessary for B cell phenotypes in DS models. Absolute exogenous-normalized chromatin immunoprecipitation sequencing (ChIP-Rx) also reveals a global increase in histone H3K27 acetylation caused by HMGN1. Transcriptional amplification downstream of HMGN1 is enriched for stage-specific programs of B cells and B cell acute lymphoblastic leukemia, dependent on the developmental cellular context. These data offer a mechanistic explanation for DS transcriptional patterns and suggest that further study of HMGN1 and RNA amplification in diverse DS phenotypes is warranted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available